BU researcher receives bioethics grant for improving long-term care facility design
Grant and Award Announcement
Updates every hour. Last Updated: 24-Oct-2026 00:17 ET (24-Oct-2026 04:17 GMT/UTC)
September 14-16 | New York, USA
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the Morgan Stanley 24th Annual Global Healthcare Conference in New York from September 14 to 16.
September 14-16 | Riyadh, Saudi Arabia
Dr. Alex Aliper, Co-Founder and President of Insilico Medicine, has been invited to attend the Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 from September 14 to 16.
September 17-19 | Shanghai, China
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the Bio-Shanghai Week 2026. On September 17 at 3:00 PM.
September 18 | Boston, USA
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the Harvard IvyTech Discussion on September 18.
Using advanced nuclear magnetic resonance (NMR) spectroscopy and clinical expertise in transfusion medicine, the Canadian team identified a hidden mechanism that controls whether a blood protein remains harmless or becomes the target of clot-causing antibodies.
Twenty-five years after the September 11 terrorist attacks, researchers at the Icahn School of Medicine at Mount Sinai have found that environmental conditions where World Trade Center responders live may influence their long-term physical and mental health.
Risk factors for cardiovascular-kidney-metabolic disease, a health condition made up of heart disease, kidney disease, diabetes, and obesity, can be identified in children as young as 8, UTHealth Houston researchers discovered.